Fig. 10
From: Insights into the pharmaceutical properties of green fabricated Iron oxide nanoparticles
A. cepa extract and Fe3O4-NPs augmented phagocytosis of pHrodo E. coli bioparticles (A), BMDMs pretreated with pHrodo E. coli bioparticles. (B) BMDMs were followed by pre-treatment with 25 µg/ml of A. cepa extract and then with pHrodo E. coli bioparticles. (C) BMDMs were followed by pre-treatment with 25 µg/ml of Fe3O4-NPs and then with pHrodo E. coli bioparticles.
